SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-22-000211
Filing Date
2022-04-07
Accepted
2022-04-07 16:07:19
Documents
6

Document Format Files

Seq Description Document Type Size
1 VERTEX PHARMACEUTICALS INC - DEFA14A lvrtx2022_defa14a.htm DEFA14A 9232
2 GRAPHIC lvrtxx1x1.jpg GRAPHIC 1316
3 GRAPHIC lvrtxx1x2.jpg GRAPHIC 985
4 GRAPHIC lvrtxx1x3.jpg GRAPHIC 7588
5 GRAPHIC lvrtxx1x4.jpg GRAPHIC 236989
6 GRAPHIC lvrtxx2x1.jpg GRAPHIC 220590
  Complete submission text file 0001308179-22-000211.txt   649446
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19319 | Film No.: 22813923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences